收费全文 | 2812篇 |
免费 | 157篇 |
国内免费 | 9篇 |
耳鼻咽喉 | 26篇 |
儿科学 | 106篇 |
妇产科学 | 94篇 |
基础医学 | 401篇 |
口腔科学 | 57篇 |
临床医学 | 215篇 |
内科学 | 609篇 |
皮肤病学 | 58篇 |
神经病学 | 236篇 |
特种医学 | 37篇 |
外科学 | 305篇 |
综合类 | 7篇 |
一般理论 | 2篇 |
预防医学 | 269篇 |
眼科学 | 38篇 |
药学 | 185篇 |
中国医学 | 12篇 |
肿瘤学 | 321篇 |
2024年 | 7篇 |
2023年 | 26篇 |
2022年 | 48篇 |
2021年 | 100篇 |
2020年 | 64篇 |
2019年 | 100篇 |
2018年 | 99篇 |
2017年 | 61篇 |
2016年 | 75篇 |
2015年 | 83篇 |
2014年 | 125篇 |
2013年 | 160篇 |
2012年 | 214篇 |
2011年 | 199篇 |
2010年 | 118篇 |
2009年 | 128篇 |
2008年 | 161篇 |
2007年 | 158篇 |
2006年 | 146篇 |
2005年 | 134篇 |
2004年 | 130篇 |
2003年 | 123篇 |
2002年 | 118篇 |
2001年 | 37篇 |
2000年 | 32篇 |
1999年 | 44篇 |
1998年 | 20篇 |
1997年 | 12篇 |
1996年 | 11篇 |
1995年 | 17篇 |
1994年 | 13篇 |
1993年 | 15篇 |
1992年 | 16篇 |
1991年 | 16篇 |
1990年 | 14篇 |
1989年 | 12篇 |
1988年 | 13篇 |
1987年 | 7篇 |
1986年 | 8篇 |
1985年 | 13篇 |
1984年 | 14篇 |
1983年 | 7篇 |
1982年 | 6篇 |
1980年 | 5篇 |
1979年 | 5篇 |
1978年 | 10篇 |
1977年 | 9篇 |
1975年 | 7篇 |
1974年 | 7篇 |
1973年 | 5篇 |
Introduction
Interstitial lung diseases (ILD) and, in particular, idiopathic pulmonary fibrosis, may have a significant impact on patient survival. Recent studies highlight the need for palliative care (PC) in the management of ILD patients. The aim of this study was to determine the current situation of PC in patients in Spain.Methods
A 36-question survey addressing the main aspects of PC in ILD patients was designed. The survey was sent via email to all members of the Spanish Society of Pulmonology and Thoracic Surgery. Participation was voluntary.Results
One hundred and sixty-four participants responded to the survey. Ninety-eight percent said they were interested in PC, 46% had received specific training, and 44% reported being responsible for PC in their ILD patients. Symptom control and end-of-life stage were the most frequent reasons for referral to PC teams. Regarding end-of-life, 78% reported consensual agreement with patients on the limitation of therapeutic efforts, 35% helped prepare an end-of-life advance directive, and 22% agreed on the place of death.Conclusion
Despite the well-known need for PC in patients with ILD and the notable interest of the survey participants in this subject, there are clear formative and organizational gaps that should be addressed to improve care in this area in ILD patients in Spain. 相似文献Cardiomyopathies are an important cause of heart failure and sudden cardiac death. Little is known about the role of rare genetic variants in inflammatory cardiomyopathy. Chronic Chagas disease cardiomyopathy (CCC) is an inflammatory cardiomyopathy prevalent in Latin America, developing in 30% of the 6 million patients chronically infected by the protozoan Trypanosoma cruzi, while 60% remain free of heart disease (asymptomatic (ASY)). The cytokine interferon-γ and mitochondrial dysfunction are known to play a major pathogenetic role. Chagas disease provides a unique model to probe for genetic variants involved in inflammatory cardiomyopathy.
MethodsWe used whole exome sequencing to study nuclear families containing multiple cases of Chagas disease. We searched for rare pathogenic variants shared by all family members with CCC but absent in infected ASY siblings and in unrelated ASY.
ResultsWe identified heterozygous, pathogenic variants linked to CCC in all tested families on 22 distinct genes, from which 20 were mitochondrial or inflammation-related – most of the latter involved in proinflammatory cytokine production. Significantly, incubation with IFN-γ on a human cardiomyocyte line treated with an inhibitor of dihydroorotate dehydrogenase brequinar (enzyme showing a loss-of-function variant in one family) markedly reduced mitochondrial membrane potential (ΔψM), indicating mitochondrial dysfunction.
ConclusionMitochondrial dysfunction and inflammation may be genetically determined in CCC, driven by rare genetic variants. We hypothesize that CCC-linked genetic variants increase mitochondrial susceptibility to IFN-γ-induced damage in the myocardium, leading to the cardiomyopathy phenotype in Chagas disease. This mechanism may also be operative in other inflammatory cardiomyopathies.
相似文献